Travere Therapeutics, Inc. (TVTX) › Weighted Average Diluted SharesTravere Therapeutics, Inc. (TVTX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2013-12-31: 14.21M2014-12-31: 25.06M2015-12-31: 37.58M2016-12-31: 38.29M2017-12-31: 38.77M2018-12-31: 40.43M2019-12-31: 42.34M2020-12-31: 47.54M2021-12-31: 59.83M2022-12-31: 63.76M2023-12-31: 74.27M2024-12-31: 78.89M2025-12-31: 89.21M89.21M2013-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3189.21M+13.1%2026-02-19From 2025-01-012024-12-3178.89M+6.2%2026-02-19From 2024-01-012023-12-3174.27M+16.5%2026-02-19From 2023-01-012022-12-3163.76M+6.6%2025-02-21From 2022-01-012021-12-3159.83M+25.9%2024-02-20From 2021-01-012020-12-3147.54M+12.3%2023-02-23From 2020-01-012019-12-3142.34M+4.7%2022-02-24From 2019-01-012018-12-3140.43M+4.3%2019-02-26From 2018-01-012017-12-3138.77M+1.3%2019-02-26From 2017-01-012016-12-3138.29M+1.9%2019-02-26From 2016-01-012015-12-3137.58M+50.0%2018-07-06From 2015-01-012014-12-3125.06M+76.4%2017-03-01From 2014-01-012013-12-3114.21M—2016-02-26From 2013-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)